Atrandi Biosciences

BioTech | Life Sciences
Year of investment: 2021
About the company:

Atrandi Biosciences ( is an emerging developer and provider of innovative microfluidic solutions for the life sciences. Its novel technology platform enables new insights into the biology of single cells, with immediate applications in research and bio-molecular discovery. Atrandi’s systems are installed in over 50 leading academic and commercial laboratories globally with a rapid growth trajectory.


Categories: Biotechnology, Life Science, Pharmaceutical

Founded: 2016 

Founder(s): Juozas Nainys, Linas Mažutis

Location(s): Vilnius, Lithuania

Entry date: 2021

Entry-stage: Seed

Latest stage: Seed

Latest round: Seed

Co-investors: Vsquared Ventures, Metaplanet, Business Angels

Exit: n/a


2021Biotech Startup Droplet Genomics Raises €1 Million From Practica Capital To Commercialize Droplet Microfluidics Technology

2023: Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology


Back to the list